Premium Nahrungsergänzungsmittel | artgerecht

Isoflurane: Effects, Uses & Side Effects

Isoflurane is a volatile inhalation anesthetic used in general anesthesia for the induction and maintenance of surgical narcosis.

Regular tips about health Regular tips about health

Things worth knowing about "Isoflurane"

Isoflurane is a volatile inhalation anesthetic used in general anesthesia for the induction and maintenance of surgical narcosis.

What is Isoflurane?

Isoflurane is a halogenated, volatile inhalation anesthetic widely used in clinical medicine for the induction and maintenance of general anesthesia. It belongs to the class of fluorinated ethers and has been one of the most commonly used inhalation anesthetics in both human and veterinary medicine since the 1980s.

Mechanism of Action

The exact mechanism of action of isoflurane is not yet fully understood. It is believed to act on multiple targets within the central nervous system:

Potentiation of GABA_A receptors: Isoflurane enhances the inhibitory effects of the neurotransmitter gamma-aminobutyric acid (GABA), resulting in suppression of neuronal activity.
Inhibition of NMDA receptors: By blocking these excitatory glutamate receptors, isoflurane reduces the transmission of pain signals and consciousness-related neural activity.
Inhibition of sodium channels: This contributes to reduced neuronal excitability.

The overall result is a dose-dependent loss of consciousness, muscle relaxation, and analgesia (pain relief).

Indications and Usage

Isoflurane is used primarily in the following clinical settings:

Induction and maintenance of general anesthesia during surgical procedures
Anesthesia in cardiac surgery, as isoflurane has cardioprotective properties (ischemic preconditioning)
Anesthesia in veterinary medicine for large and small animals
Sedation in intensive care units (in certain countries and situations)

Isoflurane is delivered via a specialized vaporizer and administered through a face mask or endotracheal tube. The minimum alveolar concentration (MAC) of isoflurane in humans is approximately 1.15 vol.% – the concentration at which 50% of patients show no response to a surgical skin incision.

Pharmacological Properties

Isoflurane has the following key pharmacological characteristics:

Blood-gas partition coefficient: 1.4 – relatively low, enabling moderately fast onset and offset of anesthesia.
Hepatic metabolism rate: Only approximately 0.2% is metabolized in the liver – significantly less than older halogenated agents such as halothane.
Vasodilation: Isoflurane causes peripheral vasodilation, which may lead to a reduction in blood pressure.
Bronchodilation: It relaxes smooth muscle in the airways, which may be beneficial in patients with asthma or bronchospasm.

Side Effects

Like all inhalation anesthetics, isoflurane may cause unwanted effects:

Cardiovascular: Hypotension (low blood pressure), reflex tachycardia (increased heart rate)
Respiratory: Respiratory depression, airway irritation, coughing (particularly during induction)
Central nervous system: Postoperative drowsiness, and rarely malignant hyperthermia (a life-threatening muscle disorder in genetically predisposed individuals)
Hepatic: In very rare cases, isoflurane-induced hepatitis may occur (far less common than with halothane).
Environmental: Isoflurane is a greenhouse gas with a high global warming potential (GWP), and its environmental impact is increasingly scrutinized in healthcare settings.

Contraindications

Known susceptibility to malignant hyperthermia
Hypersensitivity to halogenated anesthetic agents
Previous liver damage caused by halogenated anesthetics

Isoflurane Compared to Other Inhalation Anesthetics

Compared to newer agents such as sevoflurane and desflurane, isoflurane has a higher blood-gas partition coefficient, meaning a somewhat slower induction and recovery. Sevoflurane is now more commonly used for anesthesia induction due to its better airway tolerability and faster kinetics. Nevertheless, isoflurane remains globally relevant due to its favorable cost profile and well-established clinical track record.

References

Patel, S. S. & Goa, K. L. (1996). Isoflurane. Drugs, 51(3), 506–515. PubMed PMID: 8706598.
Miller, R. D. (Ed.) (2015). Miller's Anesthesia, 8th Edition. Elsevier Saunders.
World Health Organization (WHO). WHO Model List of Essential Medicines, 23rd Edition (2023). Geneva: WHO.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.